New Non-Covalent Catalyst Assembly Enables Precise Asymmetric Radical Synthesis

Researchers have developed a novel method for achieving enantioselective control in radical chemistry by utilizing the non-covalent self-assembly of chiral phosphoric acids and commercial 2-mercaptopyridines. Traditionally, controlling the stereochemistry of short-lived open-shell intermediates—such as those involved in Hydrogen Atom Transfer (HAT) reactions—has been a significant challenge in synthetic chemistry. By pairing a modular chiral phosphoric acid with an achiral thiol, the team created a dynamic, in-situ catalyst system that effectively directs the spatial orientation of chemical reactions.

This breakthrough allows for the precise manipulation of tertiary stereogenic carbons, which are fundamental components in many biological molecules and active pharmaceutical ingredients. The researchers demonstrated the utility of this platform through the photochemical deracemization of 2-aryl pyrrolidines, a common structural motif in drug design. The process relies on an 'enantioselective hydrogen atom relay,' where the self-assembled catalyst orchestrates both the abstraction and delivery of hydrogen atoms with high stereochemical fidelity.

The implications of this research are substantial for the pharmaceutical and fine chemical industries. By moving away from complex, de novo catalyst design toward a modular, combinatorial approach, chemists can now access a much broader range of asymmetric radical transformations. This strategy not only simplifies the synthesis of chiral molecules but also provides a versatile framework for future methodology development, potentially accelerating the discovery and production of complex therapeutic compounds.